Using an ensemble feature selection approach, this study successfully identified key biomarkers, including ABAT, C8B, FBXL3, and ZFP1, providing valuable insights into NAFLD to HCC disease progression. The gene discussed is ZFP1; the disease is metabolic dysfunction-associated steatotic liver disease.